Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable amyloid-beta binding activity; low-density lipoprotein particle receptor binding activity; and molecular adaptor activity. Predicted to be involved in negative regulation of cell cycle phase transition; negative regulation of transcription by RNA polymerase II; and positive regulation of protein secretion. Predicted to act upstream of or within negative regulation of apoptotic process. Predicted to be located in several cellular components, including actin cytoskeleton; cytosol; and nuclear body. Predicted to be active in cytoplasm and nucleus. Orthologous to human APBB3 (amyloid beta precursor protein binding family B member 3).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.